Trials / Conditions / EGFR-mutant Non-small Cell Lung Cancer
EGFR-mutant Non-small Cell Lung Cancer
3 registered clinical trials studyying EGFR-mutant Non-small Cell Lung Cancer — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Neoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ EGFR-mutant Non-small Ce NCT07323056 | Shanghai Pulmonary Hospital, Shanghai, China | Phase 2 |
| Unknown | A Study of Famitinib in Combination With HS-10296 in Patients With EGFR-mutant NSCLC NCT03904823 | Jiangsu HengRui Medicine Co., Ltd. | Phase 2 |
| Active Not Recruiting | Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC NCT03333343 | Novartis Pharmaceuticals | Phase 1 |